MPT SEC-arkivering - Medical Properties Trust, Inc.- Årsrapport, fuldmagtserklæring, prospekt

Grundlæggende statistik

LEI	254900U6E39J1MQCCY14
CIK	1287865

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Medical Properties Trust, Inc.

SEC Filings (Chronological Order)

Denne side giver en komplet, kronologisk liste over SEC-arkiveringer, eksklusive ejerskabsregistreringer, som vi leverer andre steder.

June 1, 2026	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 28, 2026 MEDICAL PROPERTIES T UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 28, 2026 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of inc
May 8, 2026	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2026 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file numbe
May 8, 2026	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2026 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file numbe
April 30, 2026	EX-99.2	QUARTERLY SUPPLEMENTAL 1Q 2026 AT THE VERY HEART OF HEALTHCARE.® EX-99.2 Exhibit 99.2 QUARTERLY SUPPLEMENTAL 1Q 2026 AT THE VERY HEART OF HEALTHCARE.® QUARTERLY SUPPLEMENTAL 1Q 2026 AT THE VERY HEART OF HEALTHCARE.® [Graphic Appears Here] [Graphic Appears Here] COMPANY OVERVIEW Company Information 3 FINANCIAL INFORMATION Reconciliation of Funds from Operations 6 Debt Summary 7 Debt Maturities and Debt Metrics 8 PORTFOLIO INFORMATION Lease and Loan Maturity Sche
April 30, 2026	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 30, 2026 MEDICAL PROPERTIES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 30, 2026 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of i
April 30, 2026	EX-99.1	MPT REPORTS FIRST QUARTER RESULTS EX-99.1 Exhibit 99.1 Contact: Charles Lambert Senior Vice President of Finance & Treasurer Medical Properties Trust, Inc. (205) 397-8897 [email protected] MPT REPORTS FIRST QUARTER RESULTS Birmingham, AL – April 30, 2026 – Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE: MPT) today announced financial and operating results for the first quarter ended March 31, 2026, as well as certain
April 13, 2026	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of
April 13, 2026	DEF 14A	Dear Fellow Stockholder: Elements of Pay Potential Payments Upon Termination or Change of Control Employment Arrangements with Named Executive Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of
February 26, 2026	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file
February 26, 2026	EX-21.1	SUBSIDIARIES OF REGISTRANT Exhibit 21.1 SUBSIDIARIES OF REGISTRANT Subsidiaries Jurisdiction of Organization Jurisdiction(s) in Which Qualified as a Foreign Corporation Medical Properties Trust, LLC Delaware Alabama, Massachusetts Mountain View-MPT Hospital, LLC Delaware Idaho MPT of Altoona, LLC Delaware Wisconsin MPT of Alvin FCER, LLC Delaware Texas MPT of Bayonne, LLC Delaware New Jersey MPT of Bennettsville, LLC Delawa
February 26, 2026	EX-21.1	SUBSIDIARIES OF REGISTRANT Exhibit 21.1 SUBSIDIARIES OF REGISTRANT Subsidiaries Jurisdiction of Organization Jurisdiction(s) in Which Qualified as a Foreign Corporation Medical Properties Trust, LLC Delaware Alabama, Massachusetts Mountain View-MPT Hospital, LLC Delaware Idaho MPT of Altoona, LLC Delaware Wisconsin MPT of Alvin FCER, LLC Delaware Texas MPT of Bayonne, LLC Delaware New Jersey MPT of Bennettsville, LLC Delawa
February 26, 2026	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file
February 19, 2026	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 19, 2026 MEDICAL PROPERT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 19, 2026 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction o
February 19, 2026	EX-99.1	MPT REPORTS FOURTH QUARTER AND FULL-YEAR RESULTS EX-99.1 Exhibit 99.1 Contact: Charles Lambert Senior Vice President of Finance & Treasurer Medical Properties Trust, Inc. (205) 397-8897 [email protected] MPT REPORTS FOURTH QUARTER AND FULL-YEAR RESULTS Birmingham, AL – February 19, 2026 – Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE: MPT) today announced financial and operating results for the fourth quarter and full-year ended D
February 19, 2026	EX-99.2	QUARTERLY SUPPLEMENTAL 4Q 2025 AT THE VERY HEART OF HEALTHCARE.® EX-99.2 Exhibit 99.2 QUARTERLY SUPPLEMENTAL 4Q 2025 AT THE VERY HEART OF HEALTHCARE.® COMPANY OVERVIEW FORWARD-LOOKING STATEMENTS Company Information 3 This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements can generally be iden
January 20, 2026	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 20, 2026 MEDICAL PROPERTI UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 20, 2026 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of
January 20, 2026	EX-99.1	MEDICAL PROPERTIES TRUST ISSUES LETTER TO SHAREHOLDERS REGARDING BRANDING REFRESH Announces NYSE Ticker Symbol Change to “MPT” Effective February 2, 2026 EX-99.1 Exhibit 99.1 Contact: Charles Lambert Senior Vice President of Finance & Treasurer Medical Properties Trust, Inc. (205) 397-8897 [email protected] MEDICAL PROPERTIES TRUST ISSUES LETTER TO SHAREHOLDERS REGARDING BRANDING REFRESH Announces NYSE Ticker Symbol Change to “MPT” Effective February 2, 2026 Birmingham, AL – January 20, 2026 – Medical Properties Trust, Inc. (the “Company” or “MPT”)
November 7, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file n
October 30, 2025	EX-99.1	MEDICAL PROPERTIES TRUST, INC. REPORTS THIRD QUARTER RESULTS AND OTHER UPDATES Continues Scheduled Increase in Cash Rents from New Operators Announces $150 Million Strategic Common Stock Repurchase Program EX-99.1 Exhibit 99.1 Contact: Drew Babin, CFA, CMA Head of Financial Strategy and Investor Relations Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS THIRD QUARTER RESULTS AND OTHER UPDATES Continues Scheduled Increase in Cash Rents from New Operators Announces $150 Million Strategic Common Stock Repurchase Program Birmingham, A
October 30, 2025	EX-99.2	QUARTERLY SUPPLEMENTAL 3Q 2025 AT T H E V E R Y H E A R T O F H E A LT H C A R E . EX-99.2 Exhibit 99.2 QUARTERLY SUPPLEMENTAL 3Q 2025 AT T H E V E R Y H E A R T O F H E A LT H C A R E . COMPANY OVERVIEW FORWARD-LOOKING STATEMENTS 3 This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Company Information 3 Exchange Act of 1934, as amended. Forward-looking statements c
October 30, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 30, 2025 MEDICAL PROPERTI UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 30, 2025 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of
August 14, 2025	EX-1.1	MEDICAL PROPERTIES TRUST, INC. Shares of Common Stock (par value $0.001 per share) EQUITY DISTRIBUTION AGREEMENT EX-1.1 Exhibit 1.1 MEDICAL PROPERTIES TRUST, INC. $500,000,000 Shares of Common Stock (par value $0.001 per share) EQUITY DISTRIBUTION AGREEMENT August 11, 2025 Truist Securities, Inc. Truist Securities, Inc. Truist Bank Barclays Capital Inc. Barclays Capital Inc. Barclays Bank PLC BNP Paribas Securities Corp. BNP Paribas Securities Corp. BNP PARIBAS BofA Securities, Inc. BofA Securities, Inc. Ban
August 14, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 11, 2025 MEDICAL PROPERTIE UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 11, 2025 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in its Charter) Maryland Delaware 001-32559 333-177186 20-0191742
August 11, 2025	EX-99.1	U.S. FEDERAL INCOME TAX CONSIDERATIONS EX-99.1 Exhibit 99.1 U.S. FEDERAL INCOME TAX CONSIDERATIONS This section summarizes the current material federal income tax consequences to Medical Properties and the Operating Partnership generally resulting from the treatment of Medical Properties as a REIT. Because this section is a general summary, it does not address all of the potential tax issues that may be relevant to you in light of your
August 11, 2025	EX-FILING FEES	Security Type Calculation of Filing Fee Tables S-3 MEDICAL PROPERTIES TRUST INC Table 1: Newly Registered and Carry Forward Securities ☐Not Applicable Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forward File Number Carry Forward Initial Effective Date Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward Newly Registered Securities Fees to be Paid 1 Equity Common Stock, $0.
August 11, 2025	424B5	$500,000,000 Common Stock 424B5 Filed Pursuant to Rule 424(b)(5) Registration No. 333-287726 PROSPECTUS SUPPLEMENT (To Prospectus dated June 2, 2025) $500,000,000 Common Stock We have entered into an equity distribution agreement for a continuous offering program with Truist Securities, Inc., Barclays Capital Inc., BNP Paribas Securities Corp., BofA Securities, Inc., Citizens JMP Securities, LLC, Credit Agricole Securities
August 11, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 11, 2025 MEDICAL PROPERTIE UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 11, 2025 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Commission File Numb
August 8, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file number
July 31, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 31, 2025 MEDICAL PROPERTIES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 31, 2025 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of in
July 31, 2025	EX-99.1	MEDICAL PROPERTIES TRUST, INC. REPORTS SECOND QUARTER RESULTS AND UPDATE Rapid Growth in Cash Rents from New Operators Recent Transactions Continue to Validate Asset Values and Provide Balance Sheet Flexibility Exhibit 99.1 Contact: Drew Babin, CFA, CMA Head of Financial Strategy and Investor Relations Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS SECOND QUARTER RESULTS AND UPDATE Rapid Growth in Cash Rents from New Operators Recent Transactions Continue to Validate Asset Values and Provide Balance Sheet Flexibility Birmingham, AL –
July 31, 2025	EX-99.2	QUARTERLY SUPPLEMENTAL 2Q 2025 AT T H E V E R Y H E A R T O F H E A LT H C A R E .® EX-99.2 QUARTERLY SUPPLEMENTAL 2Q 2025 AT T H E V E R Y H E A R T O F H E A LT H C A R E .® Exhibit 99.2 COMPANY OVERVIEW FORWARD-LOOKING STATEMENTS 3 This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section Company Information 3 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements
June 3, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 29, 2025 MEDICAL PROPERTIES T UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 29, 2025 MEDICAL PROPERTIES TRUST, INC. (Exact name of Registrant as Specified in Its Charter) Maryland 001-32559 20-0191742 (State or Other Jurisdiction of Incorporation) (Commis
June 2, 2025	EX-25.1	Statement of Eligibility on Form T-1 Exhibit 25.1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 ☐ Check if an Application to Determine Eligibility of a Trustee Pursuant to Section 305(b)(2) WILMINGTON TRUST, NATIONAL ASSOCIATION (Exact name of trustee as specified in its charter) 16-1486454 (I.R.S. employer identification no.) 1100 North Market Street Wilmington, DE 19890-0001 (Address of principal
June 2, 2025	S-3ASR	As filed with the Securities and Exchange Commission on June 2, 2025 Table of Contents As filed with the Securities and Exchange Commission on June 2, 2025 Registration No.
June 2, 2025	EX-FILING FEES	Calculation of Filing Fee Table Exhibit 107 Calculation of Filing Fee Table Form S-3 (Form Type) Medical Properties Trust, Inc.
May 20, 2025	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for
May 9, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file numbe
May 1, 2025	EX-99.1	MEDICAL PROPERTIES TRUST, INC. REPORTS FIRST QUARTER RESULTS Results Consistent with Expectations Following Mid-Quarter Debt Refinancing Exhibit 99.1 Contact: Drew Babin, CFA, CMA Head of Financial Strategy and Investor Relations Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS FIRST QUARTER RESULTS Results Consistent with Expectations Following Mid-Quarter Debt Refinancing Birmingham, AL – May 1, 2025 – Medical Properties Trust, Inc. (the “Company” or “MPT”) (NY
May 1, 2025	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 1, 2025 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of inco
May 1, 2025	EX-99.2	QUARTERLY SUPPLEMENTAL 1Q 2025 AT T H E V E R Y H E A R T O F H E A LT H C A R E .® Exhibit 99.2 QUARTERLY SUPPLEMENTAL 1Q 2025 AT T H E V E R Y H E A R T O F H E A LT H C A R E .® COMPANY OVERVIEW FORWARD-LOOKING STATEMENTS 3 This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section Company Information 3 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements can gene
April 17, 2025	ARS	ARS 2024 ANNUAL REPORT2 \| Medical Properties Trust Dear Shareholders, Without a doubt, 2024 was the most challenging year in MPT’s history.
April 17, 2025	DEF 14A	Dear Fellow Stockholder: Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confid
April 17, 2025	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of
March 3, 2025	EX-4.11	Twentieth Supplemental Indenture, dated as of February 28, 2025, among MPT Springstone REIT, Inc., as subsidiary guarantor, and MPT Operating Partnership, L.P. and MPT Finance Corporation, as issuers, Medical Properties Trust, Inc., as parent and guarantor, and Wilmington Trust, National Association, as trustee Exhibit 4.11 Twentieth Supplemental Indenture (this “Supplemental Indenture”), dated as of February 28, 2025, among MPT Springstone REIT, Inc. (the “Guaranteeing Subsidiary”), a subsidiary of MPT Operating Partnership L.P., a Delaware limited partnership (“Opco”), Opco, MPT Finance Corporation (“Finco” and, together with Opco, the “Issuers”), Medical Properties Trust, Inc., a Maryland corporation
March 3, 2025	EX-21.1	Subsidiaries of Medical Properties Trust, Inc. Exhibit 21.1 SUBSIDIARIES OF REGISTRANT Subsidiaries Jurisdiction of Organization Jurisdiction(s) in Which Qualified as a Foreign Corporation Medical Properties Trust, LLC Delaware Alabama, Massachusetts Mountain View-MPT Hospital, LLC Delaware Idaho MPT of Altoona, LLC Delaware Wisconsin MPT of Alvin FCER, LLC Delaware Texas MPT Bath S.a.r.l. Luxembourg — MPT of Bayonne, LLC Delaware New Jersey M
March 3, 2025	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file
February 27, 2025	EX-99.2	3 COMPANY OVERVIEWCompany Information 3FINANCIAL INFORMATION6 Reconciliation of Funds from Operations 6 Debt Summary 7 Debt Maturities and Debt Metrics 8PORTFOLIO INFORMATION Lease and Loan Maturity Schedule 99 Total Assets and Revenues by Asset Type EX-99.2 Exhibit 99.2 Exhibit 99.2 QUARTERLY SUPPLEMENTAL4Q 2024 3 COMPANY OVERVIEWCompany Information 3FINANCIAL INFORMATION6 Reconciliation of Funds from Operations 6 Debt Summary 7 Debt Maturities and Debt Metrics 8PORTFOLIO INFORMATION Lease and Loan Maturity Schedule 99 Total Assets and Revenues by Asset Type, Operator, State and Country 10 Rent Coverage 13 Summary of Acquisitions, Active Deve
February 27, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 27, 2025 MEDICAL PROPERT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 27, 2025 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction o
February 27, 2025	EX-99.1	MEDICAL PROPERTIES TRUST, INC. REPORTS FOURTH QUARTER AND FULL-YEAR RESULTS Completed Approximately $5.5 Billion of Asset Monetization Transactions, Including February’s $2.5 Billion Senior Secured Notes Offering That Addresses All Debt Maturities Th EX-99.1 Exhibit 99.1 Contact: Drew Babin, CFA, CMA Head of Financial Strategy and Investor Relations Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS FOURTH QUARTER AND FULL-YEAR RESULTS Completed Approximately $5.5 Billion of Asset Monetization Transactions, Including February’s $2.5 Billion Senior Secured Notes Offering That A
February 18, 2025	EX-10.1	Amendment No. 3 to Second Amended and Restated Revolving Credit and Term Loan Agreement, dated as of February 13, 2025, by and among Medical Properties Trust, Inc., MPT Operating Partnership, L.P., the Guarantors party hereto, the several lenders from time to time party thereto, and JPMorgan Chase Bank, N.A., as administrative agent Exhibit 10.1 AMENDMENT NO. 3 TO SECOND AMENDED AND RESTATED REVOLVING CREDIT AND TERM LOAN AGREEMENT This AMENDMENT NO. 3 TO SECOND AMENDED AND RESTATED REVOLVING CREDIT AND TERM LOAN AGREEMENT, dated as of February 13, 2025 (this “Amendment No. 3”), is by and among MEDICAL PROPERTIES TRUST, INC., a Maryland corporation (“Holdings”), MPT OPERATING PARTNERSHIP, L.P., a Delaware limited partnership
February 18, 2025	EX-4.1	Indenture, dated as of February 13, 2025, among Medical Properties Trust, Inc., MPT Operating Partnership, L.P., MPT Finance Corporation, the subsidiary guarantors party thereto, Wilmington Trust, National Association, as trustee, dollar paying agent, dollar registrar, dollar transfer agent and notes collateral agent, and U.S. Bank Europe DAC, as euro paying agent, euro registrar and euro transfer agent Exhibit 4.1 INDENTURE Dated as of February 13, 2025 Among MPT OPERATING PARTNERSHIP, L.P. and MPT FINANCE CORPORATION, as the Issuers, and MEDICAL PROPERTIES TRUST, INC., as Parent and a Guarantor, and SUBSIDIARIES PARTY HERETO, as Subsidiary Guarantors, and WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee, Dollar Paying Agent, Dollar Registrar, Dollar Transfer Agent and Notes Collateral Agent,
February 18, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 13, 2025 MEDICAL PROPERT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 13, 2025 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Commission File Nu
February 6, 2025	EX-99.4P PWR ATTY	EX-99.4P PWR ATTY EXHIBIT 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree that the Schedule 13G/A filed is filed on behalf of myself. Date: 2025-02-06 /S/ Zhengxu He Name: ZHENGXU HE Title: Mr.
January 31, 2025	EX-99.1	MEDICAL PROPERTIES TRUST ANNOUNCES PRICING OF $1.5 BILLION 8.500% SENIOR SECURED NOTES DUE 2032 AND €1.0 BILLION 7.000% SENIOR SECURED NOTES DUE 2032 Pricing Represents a Blended Coupon of 7.885% EX-99.1 Exhibit 99.1 Contact: Drew Babin, CFA, CMA Head of Financial Strategy and Investor Relations Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST ANNOUNCES PRICING OF $1.5 BILLION 8.500% SENIOR SECURED NOTES DUE 2032 AND €1.0 BILLION 7.000% SENIOR SECURED NOTES DUE 2032 Pricing Represents a Blended Coupon of 7.885% Birmingham, AL – Januar
January 31, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 30, 2025 MEDICAL PROPERTI UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 30, 2025 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Commission File Num
January 29, 2025	EX-99.1	Recent Developments EX-99.1 Exhibit 99.1 Recent Developments Disposition and Recovery Transactions During the year ended December 31, 2024, we strategically disposed of properties and received insurance proceeds aggregating approximately $2.0 billion, as further detailed below, and realized net real estate gains of approximately $570 million. On April 9, 2024, we completed the sale of five properties to Prime Healthc
January 29, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 29, 2025 MEDICAL PROPERTI UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 29, 2025 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Commission File Num
January 29, 2025	EX-99.2	# # # EX-99.2 Exhibit 99.2 Contact: Drew Babin, CFA, CMA Head of Financial Strategy and Investor Relations Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST ANNOUNCES PRIVATE OFFERING OF SENIOR SECURED NOTES Birmingham, AL – January 29, 2025 – Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE: MPW) today announced that its operating part
November 13, 2024	EX-10.1	Amendment No. 2 to Second Amended and Restated Revolving Credit and Term Loan Agreement, dated as of August 6, 2024, by and among Medical Properties Trust, Inc., MPT Operating Partnership, L.P., the Guarantors party hereto, the several lenders from time to time party thereto, and JPMorgan Chase Bank, N.A., as administrative agent Exhibit 10.1 AMENDMENT NO. 2 TO SECOND AMENDED AND RESTATED REVOLVING CREDIT AND TERM LOAN AGREEMENT This AMENDMENT NO. 2 TO SECOND AMENDED AND RESTATED REVOLVING CREDIT AND TERM LOAN AGREEMENT, dated as of August 6, 2024 (this “Amendment No. 2”), is by and among MEDICAL PROPERTIES TRUST, INC., a Maryland corporation (“Holdings”), MPT OPERATING PARTNERSHIP, L.P., a Delaware limited partnership (th
November 13, 2024	10-Q/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A (Amendment No.1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A (Amendment No.1) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-3255
November 12, 2024	EX-10.1	Amendment No. 2 to Second Amended and Restated Revolving Credit and Term Loan Agreement, dated as of August 6, 2024, by and among Medical Properties Trust, Inc., MPT Operating Partnership, L.P., the Guarantors party hereto, the several lenders from time to time party thereto, and JPMorgan Chase Bank, N.A., as administrative agent Exhibit 10.1 AMENDMENT NO. 2 TO SECOND AMENDED AND RESTATED REVOLVING CREDIT AND TERM LOAN AGREEMENT This AMENDMENT NO. 2 TO SECOND AMENDED AND RESTATED REVOLVING CREDIT AND TERM LOAN AGREEMENT, dated as of August 6, 2024 (this “Amendment No. 2”), is by and among MEDICAL PROPERTIES TRUST, INC., a Maryland corporation (“Holdings”), MPT OPERATING PARTNERSHIP, L.P., a Delaware limited partnership (th
November 12, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file n
November 8, 2024	SC 13G/A	MPW / Medical Properties Trust, Inc. / BlackRock, Inc. Passive Investment us58463j3041110824.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 3) MEDICAL PROPERTIES TRUST INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 58463J304 - (CUSIP Number) September 30, 2024 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule
November 7, 2024	EX-99.2	Medical Properties Trust QUARTERLY SUPPLEMENTAL 3Q 2024 Exhibit 99.2 Medical Properties Trust QUARTERLY SUPPLEMENTAL 3Q 2024 3 COMPANY OVERVIEW Company Information 3 FINANCIAL INFORMATION 6 Reconciliation of Funds from Operations 6 Debt Summary 7 Debt Maturities and Debt Metrics 8 PORTFOLIO INFORMATION Lease and Loan Maturity Schedule 9 9 Total Assets and Revenues by Asset Type, Operator, State and Country 10 Rent Coverage 13 Summary of Investments and
November 7, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 7, 2024 MEDICAL PROPERTI UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 7, 2024 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of
November 7, 2024	EX-99.1	MEDICAL PROPERTIES TRUST, INC. REPORTS THIRD QUARTER RESULTS Operations of 17 Former Steward Hospitals Transitioned to Five New Operators Approximately $2.9 Billion of Year-to-Date Liquidity Transactions Completed EX-99.1 Exhibit 99.1 Contact: Drew Babin, CFA, CMA Head of Financial Strategy and Investor Relations Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS THIRD QUARTER RESULTS Operations of 17 Former Steward Hospitals Transitioned to Five New Operators Approximately $2.9 Billion of Year-to-Date Liquidity Transactions Completed Birmi
October 24, 2024	SC 13G	MPW / Medical Properties Trust, Inc. / He Zhengxu - SC13G_MPW_2024_10 Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.
October 23, 2024	SC 13G/A	MPW / Medical Properties Trust, Inc. / BlackRock, Inc. Passive Investment us58463j3041102324.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 3) MEDICAL PROPERTIES TRUST INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 58463J304 - (CUSIP Number) September 30, 2024 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule
September 17, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 11, 2024 MEDICAL PROPER UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 11, 2024 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Commission File N
August 9, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file number
August 9, 2024	EX-10.1	Amendment No. 1 to Second Amended and Restated Revolving Credit and Term Loan Agreement, dated as of April 12, 2024, by and among Medical Properties Trust, Inc., MPT Operating Partnership, L.P., the Guarantors party hereto, the several lenders from time to time party thereto, and JPMorgan Chase Bank, N.A., as administrative agent Exhibit 10.1 AMENDMENT NO. 1 TO SECOND AMENDED AND RESTATED REVOLVING CREDIT AND TERM LOAN AGREEMENT This AMENDMENT NO. 1 TO SECOND AMENDED AND RESTATED REVOLVING CREDIT AND TERM LOAN AGREEMENT, dated as of April 12, 2024 (this “Amendment No. 1”), is by and among MEDICAL PROPERTIES TRUST, INC., a Maryland corporation (“Holdings”), MPT OPERATING PARTNERSHIP, L.P., a Delaware limited partnership (th
August 8, 2024	EX-99.2	QUARTERLY SUPPLEMENTAL 2Q 2024 EX-99.2 Exhibit 99.2 QUARTERLY SUPPLEMENTAL 2Q 2024 Pictured above: Klinik am Burggraben—Bad Salzuflen, Germany—Operated by MEDIAN. On the cover: Málaga Center of Excellence—Málaga, Spain—Operated by GenesisCare. FORWARD-LOOKING STATEMENTS This press release includes forward-looking statements within the meaning COMPANY OVERVIEW of Section 27A of the Securities Act of 1933, as amended, and Section
August 8, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 8, 2024 MEDICAL PROPERTIES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 8, 2024 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Commission File Numbe
August 8, 2024	EX-99.1	MEDICAL PROPERTIES TRUST, INC. REPORTS SECOND QUARTER RESULTS Successfully Executed More than $2.5 Billion in Year-to-Date Liquidity Transactions Modified Credit Facility Terms and Conditions Exhibit 99.1 Contact: Drew Babin, CFA, CMA Head of Financial Strategy and Investor Relations Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS SECOND QUARTER RESULTS Successfully Executed More than $2.5 Billion in Year-to-Date Liquidity Transactions Modified Credit Facility Terms and Conditions Birmingham, AL – August 8, 2024 – M
June 3, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 30, 2024 MEDICAL PROPERTIES T UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 30, 2024 MEDICAL PROPERTIES TRUST, INC. (Exact name of Registrant as Specified in Its Charter) Maryland 001-32559 20-0191742 (State or Other Jurisdiction of Incorporation) (Commis
May 29, 2024	EX-10.1	Amendment to Second Amended and Restated Master Lease Agreement between certain subsidiaries of MPT Operating Partnership, L.P. as Lessor and certain subsidiaries of Steward Health Care System LLC, Lessee Exhibit 10.1 AMENDMENT TO SECOND AMENDED AND RESTATED MASTER LEASE AGREEMENT (Stewardship Note) THIS AMENDMENT TO SECOND AMENDED AND RESTATED MASTER LEASE AGREEMENT (this “Amendment”), dated January 2, 2024, is by and among certain Affiliates of MPT OPERATING PARTNERSHIP, L.P., a Delaware limited partnership (“MPT”), as further described on the signature pages hereto (collectively, jointly and sev
May 29, 2024	8-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 9, 2024 M UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 9, 2024 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Maryland 001-32559 20-0191742 (State or other jurisdiction of incorpo
May 29, 2024	EX-99.1	QUARTERLY SUPPLEMENTAL 1Q 2024 (UPDATED) EX-99.1 Exhibit 99.1 QUARTERLY SUPPLEMENTAL 1Q 2024 (UPDATED) No Spacing;MEDICAL PROPERTIES TRUST \| SUPPLEMENTAL INFORMATION \| Q1 2024 2 COMPANY OVERVIEW Company Information 3 FINANCIAL INFORMATION Reconciliation of Funds from Operations 6 Debt Summary 7 Debt Maturities and Debt Metrics 8 PORTFOLIO INFORMATION Lease and Loan Maturity Schedule 9 Total Assets and Revenues by Asset Type, Operator, St
May 29, 2024	EX-10.2	Second Amendment to Second Amended and Restated Master Lease Agreement between certain subsidiaries of MPT Operating Partnership, L.P. as Lessor and certain subsidiaries of Steward Health Care System LLC, Lessee Exhibit 10.2 AMENDMENT TO SECOND AMENDED AND RESTATED MASTER LEASE AGREEMENT (2024 Bridge Loan and Second Forbearance Agreement) THIS AMENDMENT TO SECOND AMENDED AND RESTATED MASTER LEASE AGREEMENT (this “Amendment”), dated February 21, 2024, is by and among certain Affiliates of MPT OPERATING PARTNERSHIP, L.P., a Delaware limited partnership (“MPT”), as further described on the signature pages he
May 29, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file numbe
May 28, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 21, 2024 MEDICAL PROPERTIES T UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 21, 2024 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Commission File Number
May 22, 2024	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidenti
May 16, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 16, 2024 MEDICAL PROPERTIES T UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 16, 2024 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Commission File Number
May 16, 2024	EX-99.1	MEDICAL PROPERTIES TRUST COMMENTS ON DELAYED FORM 10-Q FILING AND RELATED NOTICE FROM NYSE Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director of Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST COMMENTS ON DELAYED FORM 10-Q FILING AND RELATED NOTICE FROM NYSE Birmingham, AL – May 16, 2024 – As described in the Form 12b-25 previously filed by Medical Properties Trust, Inc. (the “Company” or
May 13, 2024	NT 10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: March 31, 2024 SEC File Numbers: 001-32559, 333-177186 CUSIP Number: 58463J304 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
May 10, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 6, 2024 MEDICAL PROPERTIES TR UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 6, 2024 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 Dela
May 9, 2024	EX-99.2	Medical Properties Trust EX-99.2 Exhibit 99.2 Medical Properties Trust QUARTERLY SUPPLEMENTAL 1Q 2024 COMPANY OVERVIEW Company Information 3 FINANCIAL INFORMATION 6 Reconciliation of Funds from Operations 6 Debt Summary 7 Debt Maturities and Debt Metrics 8 PORTFOLIO INFORMATION Lease and Loan Maturity Schedule 9 9 Total Assets and Revenues by Asset Type, Operator, State and Country 10 Rent Coverage 13 Summary of Invest
May 9, 2024	EX-99.1	MEDICAL PROPERTIES TRUST, INC. REPORTS FIRST QUARTER RESULTS Executed Total Liquidity Transactions of $1.6 Billion Year-to-Date, or 80% of MPT’s Initial FY 2024 Target Debt, Net of Cash, Reduced by Approximately $1.6 Billion Since the First Quarter o EX-99.1 Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director of Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS FIRST QUARTER RESULTS Executed Total Liquidity Transactions of $1.6 Billion Year-to-Date, or 80% of MPT’s Initial FY 2024 Target Debt, Net of Cash, Reduced by Approximately $1.6
May 9, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 9, 2024 MEDICAL PROPERTIES TR UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 9, 2024 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of inco
May 7, 2024	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 6, 2024 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Maryland 001-32559 20-0191742 Delaware 333-177186 20-0242
April 18, 2024	EX-99.2	MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES MPT OPERATING PARTNERSHIP, L.P. AND SUBSIDIARIES UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL INFORMATION EX-99.2 Exhibit 99.2 MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES MPT OPERATING PARTNERSHIP, L.P. AND SUBSIDIARIES UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL INFORMATION Joint Venture Transaction These unaudited pro forma condensed consolidated financial statements of Medical Properties Trust, Inc. and subsidiaries, and of MPT Operating Partnership, L.P. and subsidiaries have been pre
April 18, 2024	8-K	Regulation FD Disclosure, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 12, 2024 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Commission File Numbe
April 18, 2024	EX-99.1	MEDICAL PROPERTIES TRUST SELLS MAJORITY INTEREST IN UTAH HOSPITALS Generates Approximately $1.1 Billion of Total Cash Proceeds to MPT Brings Total Liquidity Transactions Year-to-Date to $1.6 Billion, or 80% of MPT’s Initial FY 2024 Target EX-99.1 Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director of Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST SELLS MAJORITY INTEREST IN UTAH HOSPITALS Generates Approximately $1.1 Billion of Total Cash Proceeds to MPT Brings Total Liquidity Transactions Year-to-Date to $1.6 Billion, or 80% of MPT’
April 17, 2024	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for
April 17, 2024	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐
April 17, 2024	ARS	ARS 2023 ANNUAL REPORT2 \| Medical Properties Trust 20 Years in Business MPW NYSE:LISTED $18.
March 14, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 8, 2024 MEDICAL PROPERTIES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 8, 2024 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of in
March 14, 2024	EX-10.1	Form of Award Agreement for Restricted Stock Units EX-10.1 Exhibit 10.1 MEDICAL PROPERTIES TRUST, INC. AMENDED AND RESTATED 2019 EQUITY INCENTIVE PLAN AWARD AGREEMENT FOR CASH-SETTLED RESTRICTED STOCK UNITS THIS AWARD AGREEMENT (the “Agreement”) is made effective and entered into with an award grant date as of March 8, 2024 (the “Grant Date”) by and between MEDICAL PROPERTIES TRUST, INC., a Maryland corporation (the “Company”), and (the “Participa
February 29, 2024	EX-19.2	Insider Trading Policy Exhibit 19.2 MEDICAL PROPERTIES TRUST, INC. Insider Trading Policy Revised August 18, 2016 Important: Any director or employee who wishes to trade in the Company's securities must contact the Chief Financial Officer (the "CFO ") for approval prior to making such trade. Background Federal securities laws prohibit (i) buying or selling a company's securities by anyone who is aware of material nonpub
February 29, 2024	EX-19.1	Compensation Recovery Policy Exhibit 19.1 MEDICAL PROPERTIES TRUST, INC. COMPENSATION RECOVERY POLICY Adopted as of November 9, 2023 Medical Properties Trust, Inc., a Maryland corporation (the “Company”), has adopted a Compensation Recovery Policy (this “Policy”) as described below. This Policy supersedes and replaces the Company’s Clawback Policy adopted in 2013 (the “Prior Policy”) with respect to Incentive-Based Compensati
February 29, 2024	LETTER	LETTER United States securities and exchange commission logo February 29, 2024 R. Steven Hamner Chief Financial Officer Medical Properties Trust, Inc. MPT Operating Partnership, L.P. 1000 Urban Center Drive, Suite 501 Birmingham, AL 35242 Re: Medical Properties Trust, Inc. MPT Operating Partnership, L.P. Form 10-K for the Year Ended December 31, 2021 Form 10-K for the Year Ended December 31, 2022 File No
February 29, 2024	EX-21.1	Subsidiaries of Medical Properties Trust, Inc. Exhibit 21.1 SUBSIDIARIES OF REGISTRANT Subsidiaries Jurisdiction of Organization Jurisdiction(s) in Which Qualified as a Foreign Corporation Medical Properties Trust, LLC Delaware Alabama, Massachusetts Mountain View-MPT Hospital, LLC Delaware Idaho MPT of Altoona, LLC Delaware Wisconsin MPT of Alvin FCER, LLC Delaware Texas MPT Bath S.a.r.l. Luxembourg — MPT of Bayonne, LLC Delaware New Jersey M
February 29, 2024	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file
February 21, 2024	EX-99.1	MEDICAL PROPERTIES TRUST, INC. REPORTS FOURTH QUARTER AND FULL-YEAR RESULTS Accelerated Asset Divestiture Strategy with More Than $480 million of Liquidity Transactions EX-99.1 Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director of Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS FOURTH QUARTER AND FULL-YEAR RESULTS Accelerated Asset Divestiture Strategy with More Than $480 million of Liquidity Transactions Birmingham, AL – February 21, 2024 – Medical Pr
February 21, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 21, 2024 MEDICAL PROPERT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 21, 2024 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction o
February 21, 2024	EX-99.2	QUARTERLY SUPPLEMENTAL FOURTH QUARTER 2023 EX-99.2 Exhibit 99.2 QUARTERLY SUPPLEMENTAL FOURTH QUARTER 2023 3 COMPANY OVERVIEW Company Information 3 FINANCIAL INFORMATION 6 Reconciliation of Funds from Operations 6 Debt Summary 7 Debt Maturities and Debt Metrics 8 PORTFOLIO INFORMATION Lease and Loan Maturity Schedule 9 9 Total Assets and Revenues by Asset Type, Operator, State and Country 10 Rent Coverage 13 Summary of Investments and Deve
February 13, 2024	SC 13G/A	MPW / Medical Properties Trust, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 18)* Name of issuer: Medical Properties Trust Inc Title of Class of Securities: Common Stock CUSIP Number: 58463J304 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the rule pursuant to which this Schedule i
February 8, 2024	CORRESP	February 8, 2024 February 8, 2024 VIA EDGAR United States Securities and Exchange Commission Division of Corporate Finance Office of Real Estate and Construction 100 F Street, NE Washington, D.
January 30, 2024	SC 13G/A	MPW / Medical Properties Trust, Inc. / STATE STREET CORP Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 AMENDED FILING MEDICAL PROPERTIES TRUST INC (NAME OF ISSUER) REIT (TITLE OF CLASS OF SECURITIES) 58463J304 (CUSIP NUMBER) 12/31/2023 (DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT) CHECK THE APPROPRIATE BOX TO DESIGNATE THE RULE PURSUANT TO WHICH THIS SCHEDULE IS F
January 25, 2024	LETTER	LETTER July 3, 2023 R. Steven Hamner Chief Financial Officer Medical Properties Trust, Inc. MPT Operating Partnership, L.P. 1000 Urban Center Drive, Suite 501 Birmingham, AL 35242 Re: Medical Properties Trust, Inc. MPT Operating Partnership, L.P. Form 10-K for the Year Ended December 31, 2022 Filed March 1, 2023 File No. 001-32559 Dear R. Steven Hamner: We received your letters dated February 8, 2023 and
January 25, 2024	LETTER	LETTER United States securities and exchange commission logo January 25, 2024 R. Steven Hamner Chief Financial Officer Medical Properties Trust, Inc. MPT Operating Partnership, L.P. 1000 Urban Center Drive, Suite 501 Birmingham, AL 35242 Re: Medical Properties Trust, Inc. MPT Operating Partnership, L.P. Form 10-K for the Year Ended December 31, 2021 Form 10-K for the Year Ended December 31, 2022 File No.
January 24, 2024	CORRESP	January 24, 2024 January 24, 2024 VIA EDGAR United States Securities and Exchange Commission Division of Corporate Finance Office of Real Estate and Construction 100 F Street, NE Washington, D.
January 23, 2024	SC 13G/A	MPW / Medical Properties Trust, Inc. / BlackRock Inc. Passive Investment us58463j3041012324.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 2) MEDICAL PROPERTIES TRUST INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 58463J304 - (CUSIP Number) December 31, 2023 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule p
January 9, 2024	LETTER	LETTER United States securities and exchange commission logo January 9, 2024 R. Steven Hamner Chief Financial Officer Medical Properties Trust, Inc. MPT Operating Partnership, L.P. 1000 Urban Center Drive, Suite 501 Birmingham, AL 35242 Re: Medical Properties Trust, Inc. MPT Operating Partnership, L.P. Form 10-K for the Year Ended December 31, 2022 File No. 001-32559 Dear R. Steven Hamner: We have review
January 5, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 2, 2024 MEDICAL PROPERTIE UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 2, 2024 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Commission File Numb
January 5, 2024	EX-99.1	MEDICAL PROPERTIES TRUST PROVIDES UPDATE ON STEWARD HEALTH CARE EX-99.1 Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director of Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST PROVIDES UPDATE ON STEWARD HEALTH CARE Birmingham, AL – January 4, 2024 – Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE: MPW) today announced plans to accelerate its efforts t
December 14, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 8, 2023 MEDICAL PROPERTI UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 8, 2023 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of
December 14, 2023	EX-10.1	Form of Award Agreement for Restricted Stock*** EX-10.1 Exhibit 10.1 MEDICAL PROPERTIES TRUST, INC. AMENDED AND RESTATED 2019 EQUITY INCENTIVE PLAN AWARD AGREEMENT FOR RESTRICTED STOCK THIS AWARD AGREEMENT (the “Agreement”) is made effective and entered into with an award grant date as of December , 2023 (the “Grant Date”) by and between MEDICAL PROPERTIES TRUST, INC., a Maryland corporation (the “Company”), and (the “Participant”) pursuant to
November 21, 2023	CORRESP	November 21, 2023 November 21, 2023 VIA EDGAR United States Securities and Exchange Commission Division of Corporate Finance Office of Real Estate and Construction 100 F Street, NE Washington, D.
November 9, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file n
November 7, 2023	LETTER	LETTER United States securities and exchange commission logo November 7, 2023 R. Steven Hamner Chief Financial Officer Medical Properties Trust, Inc. MPT Operating Partnership, L.P. 1000 Urban Center Drive, Suite 501 Birmingham, AL 35242 Re: Medical Properties Trust, Inc. MPT Operating Partnership, L.P. Form 10-K for the Year Ended December 31, 2022 File No. 001-32559 Dear R. Steven Hamner: We have revie
October 26, 2023	EX-99.2	Medical Properties Trust QUARTERLY SUPPLEMENTAL THIRD QUARTER 2023 EX-99.2 Exhibit 99.2 Medical Properties Trust QUARTERLY SUPPLEMENTAL THIRD QUARTER 2023 THIRD QUARTER 2023 COMPANY OVERVIEW Company Information 3 FINANCIAL INFORMATION Reconciliation of Net Income to Funds from Operations 6 Debt Summary 7 Debt Maturities and Debt Metrics 8 PORTFOLIO INFORMATION Lease and Loan Maturity Schedule 9 Total Assets and Revenues by Asset Type, Operator, State and Country
October 26, 2023	EX-99.1	MEDICAL PROPERTIES TRUST, INC. CONFIRMS LONG-TERM STRENGTH, STABILITY AND PERFORMANCE OF BUSINESS MODEL IN THIRD QUARTER RESULTS Per Share Net Income of $0.19 and Normalized FFO of $0.38 in Third Quarter Expected Liquidity Transactions in the Next Tw EX-99.1 Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director of Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. CONFIRMS LONG-TERM STRENGTH, STABILITY AND PERFORMANCE OF BUSINESS MODEL IN THIRD QUARTER RESULTS Per Share Net Income of $0.19 and Normalized FFO of $0.38 in Third Quarter Expected Liq
October 26, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 26, 2023 MEDICAL PROPERTI UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 26, 2023 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of
August 9, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file number
August 8, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 8, 2023 MEDICAL PROPERTIES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 8, 2023 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of i
August 8, 2023	EX-99.1	MEDICAL PROPERTIES TRUST, INC. REPORTS SECOND QUARTER RESULTS Per Share Net Loss of ($0.07) and Normalized FFO of $0.48 in Second Quarter EX-99.1 Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director of Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS SECOND QUARTER RESULTS Per Share Net Loss of ($0.07) and Normalized FFO of $0.48 in Second Quarter Birmingham, AL – August 8, 2023 – Medical Properties Trust, Inc. (the “Company
August 8, 2023	EX-99.2	MPT Medical Properties Trust QUARTERLY SUPPLEMENTAL SECOND QUARTER 2023 EX-99.2 Exhibit 99.2 MPT Medical Properties Trust QUARTERLY SUPPLEMENTAL SECOND QUARTER 2023 3 COMPANY OVERVIEW Company Information 3 FINANCIAL INFORMATION 6 Reconciliation of Net Income to Funds from Operations 6 Debt Summary 7 Debt Maturities and Debt Metrics 8 PORTFOLIO INFORMATION Lease and Loan Maturity Schedule 9 9 Total Assets and Revenues by Asset Type, Operator, State and Country 10 Rent
July 18, 2023	CORRESP	July 18, 2023 July 18, 2023 VIA EDGAR United States Securities and Exchange Commission Division of Corporate Finance Office of Real Estate and Construction 100 F Street, NE Washington, D.
July 3, 2023	LETTER	LETTER United States securities and exchange commission logo July 3, 2023 R. Steven Hamner Chief Financial Officer Medical Properties Trust, Inc. MPT Operating Partnership, L.P. 1000 Urban Center Drive, Suite 501 Birmingham, AL 35242 Re: Medical Properties Trust, Inc. MPT Operating Partnership, L.P. Form 10-K for the Year Ended December 31, 2022 Filed March 1, 2023 File No. 001-32559 Form 8-K Filed Febru
May 26, 2023	8-K	Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 25, 2023 MEDICAL PROPERTIES TRUST, INC. (Exact name of Registrant as Specified in Its Charter) Maryland 001-32559 20-0191742 (State or Other Jurisdiction of Incorporation) (Commis
May 25, 2023	EX-99.1	MEDICAL PROPERTIES TRUST ANNOUNCES PROSPECT RECAPITALIZATION TRANSACTIONS Third-Party Lenders Invest $375 Million in Prospect Proceeds Fully Repay Prospect’s ABL Facility EX-99.1 Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director – Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST ANNOUNCES PROSPECT RECAPITALIZATION TRANSACTIONS Third-Party Lenders Invest $375 Million in Prospect Proceeds Fully Repay Prospect’s ABL Facility Birmingham, AL – May 23, 2023 – Medical Proper
May 25, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 23, 2023 MEDICAL PROPERTIES T UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 23, 2023 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Commission File Number
May 10, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file numbe
April 27, 2023	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confid
April 27, 2023	ARS	ARS 2022 ANNUAL REPORT 3 ANNUAL REPORT ࣉࣇࣉࣉ IN DEMANDMEDICAL PROPERTIES TRUST , INC. 4 ON THE COVER AND ABOVE: MOUNTAIN POINT MEDICAL CENTER - LEHI, UTAH2022 ANNUAL REPORT 1 CONTENTS 02 SHAREHOLDER LETTER 04 THE NUCLEUS 08 EXPANDING CHOICE 10 MAKING AN IMPACT EVERY DAY 14 TIME TO SHINE 18 THE BEST AND THE BRIGHTEST 24 LEADING THE TEAM 26 FINANCIAL REVIEW TABLE OFMEDICAL PROPERTIES TRUST , INC. 2 A TIM
April 27, 2023	EX-99.1	EX-99.1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) È ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ‘ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file
April 27, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 27, 2023 MEDICAL PROPERTIES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 27, 2023 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of i
April 27, 2023	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, fo
April 27, 2023	EX-99.2	QUARTERLY SUPPLEMENTAL FIRST QUARTER 2023 EX-99.2 Exhibit 99.2 QUARTERLY SUPPLEMENTAL FIRST QUARTER 2023 FORWARD-LOOKING STATEMENTS COMPANY OVERVIEW Forward-looking statements involve known and unknown 3 risks, uncertainties and other factors that may cause the actual results of the Company or future events to differ Company Information 3 materially from those expressed in or underlying such forward-looking statements, including without l
April 27, 2023	EX-99.1	MEDICAL PROPERTIES TRUST, INC. REPORTS FIRST QUARTER RESULTS Per Share Net Income of $0.05 and Normalized FFO of $0.37 in First Quarter Recent Transactions Validate Underwritten Values; Provides Additional Capital Flexibility Declared Second Quarter EX-99.1 Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director of Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS FIRST QUARTER RESULTS Per Share Net Income of $0.05 and Normalized FFO of $0.37 in First Quarter Recent Transactions Validate Underwritten Values; Provides Additional Capital Fl
April 10, 2023	EX-99.1	MEDICAL PROPERTIES TRUST RESPONDS TO WALL STREET JOURNAL ARTICLE EX-99.1 Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director – Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST RESPONDS TO WALL STREET JOURNAL ARTICLE Birmingham, AL – April 7, 2023 – Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE: MPW) today issued a statement to address content of a Wa
April 10, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 7, 2023 MEDICAL PROPERTIES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 7, 2023 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of in
March 31, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 30, 2023 MEDICAL PROPERTIES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 30, 2023 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of i
March 31, 2023	EX-99.1	MEDICAL PROPERTIES TRUST FILES LAWSUIT AGAINST SHORT-SELLER VICEROY RESEARCH AND ITS MEMBERS, SENDS LETTER TO SHAREHOLDERS Viceroy’s Numerous Defamatory, False and Misleading Claims Have Caused Serious Harm to MPT and its Investors Shareholder Letter EX-99.1 Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director – Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST FILES LAWSUIT AGAINST SHORT-SELLER VICEROY RESEARCH AND ITS MEMBERS, SENDS LETTER TO SHAREHOLDERS Viceroy’s Numerous Defamatory, False and Misleading Claims Have Caused Serious Harm to MPT and
March 24, 2023	CORRESP	March 24, 2023 March 24, 2023 VIA EDGAR United States Securities and Exchange Commission Division of Corporate Finance Office of Real Estate and Construction 100 F Street, NE Washington, D.
March 1, 2023	EX-21	Subsidiaries of Medical Properties Trust, Inc. Exhibit 21.1 SUBSIDIARIES OF REGISTRANT Subsidiaries Jurisdiction of Organization Jurisdiction(s) in Which Qualified as a Foreign Corporation Medical Properties Trust, LLC Delaware Alabama, Massachusetts Mountain View-MPT Hospital, LLC Delaware Idaho MPT of Altoona, LLC Delaware Wisconsin MPT of Alvarado, LLC Delaware California MPT of Alvarado, L.P. Delaware California MPT of Alvin FCER, LLC Dela
March 1, 2023	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file
February 27, 2023	EX-99.1	Fourth Quarter 2022 Supplemental Update FEBRUARY 2023 EX-99.1 Exhibit 99.1 Fourth Quarter 2022 Supplemental Update FEBRUARY 2023 FORWARD-LOOKING STATEMENTS This presentation includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements can generally be identified by the use of forward-looking words such as
February 27, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 27, 2023 MEDICAL PROPERT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 27, 2023 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Maryland 001-32559 20-0191742 (State or other jurisdiction of incorporation or orga
February 23, 2023	EX-99.2	Q4 2022SUPPLEMENTAL EX-99.2 Exhibit 99.2 Q4 2022SUPPLEMENTAL COMPANY OVERVIEWCompany Information 3FINANCIAL INFORMATIONReconciliation of Net Income to Funds from Operations 6Debt Summary 7Adjusted Net Debt / Annualized EBITDAre 8PORTFOLIO INFORMATIONAdjusted Lease and Loan Maturity Schedule 9Total Assets and Revenuesby Asset Type, Operator, State and Country 10Rent Coverage 13Summary of Investments and Development Pr
February 23, 2023	EX-99.1	CO-FOUNDER EMMETT E. MCLEAN TO RETIRE AS MEDICAL PROPERTIES TRUST EXECUTIVE VICE PRESIDENT, CHIEF OPERATING OFFICER AND SECRETARY EX-99.1 Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director of Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] CO-FOUNDER EMMETT E. MCLEAN TO RETIRE AS MEDICAL PROPERTIES TRUST EXECUTIVE VICE PRESIDENT, CHIEF OPERATING OFFICER AND SECRETARY Birmingham, AL – February 23, 2023 – Medical Properties Trust, Inc. (the “Company” or
February 23, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 23, 2023 MEDICAL PROPERT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 23, 2023 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction o
February 23, 2023	EX-99.1	MEDICAL PROPERTIES TRUST, INC. REPORTS FOURTH QUARTER AND FULL-YEAR RESULTS Per Share Net Loss of ($0.24) and Normalized FFO of $0.43 in Fourth Quarter 35% Growth in Net Income and 4% Growth in Both NFFO and AFFO, on a Per Share Basis, in Full-Year 2 EX-99.1 Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director of Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS FOURTH QUARTER AND FULL-YEAR RESULTS Per Share Net Loss of ($0.24) and Normalized FFO of $0.43 in Fourth Quarter 35% Growth in Net Income and 4% Growth in Both NFFO and AFFO, on
February 23, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 16, 2023 MEDICAL PROPERT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 16, 2023 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction o
February 9, 2023	SC 13G/A	MPW / Medical Properties Trust, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 17)* Name of issuer: Medical Properties Trust Inc. Title of Class of Securities: REIT CUSIP Number: 58463J304 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pursuant to which this Schedule is filed
February 8, 2023	CORRESP	February 8, 2023 February 8, 2023 VIA EDGAR United States Securities and Exchange Commission Division of Corporate Finance Office of Real Estate and Construction 100 F Street, NE Washington, D.
February 3, 2023	SC 13G/A	MPW / Medical Properties Trust, Inc. / STATE STREET CORP Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 AMENDED FILING MEDICAL PROPERTIES TRUST INC (NAME OF ISSUER) REIT (TITLE OF CLASS OF SECURITIES) 58463J304 (CUSIP NUMBER) 12/31/2022 (DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT) CHECK THE APPROPRIATE BOX TO DESIGNATE THE RULE PURSUANT TO WHICH THIS SCHEDULE IS F
January 26, 2023	SC 13G/A	MPW / Medical Properties Trust, Inc. / BlackRock Inc. Passive Investment us58463j3041012623.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 1) MEDICAL PROPERTIES TRUST INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 58463J304 - (CUSIP Number) December 31, 2022 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule p
January 25, 2023	LETTER	LETTER United States securities and exchange commission logo January 25, 2023 R. Steven Hamner Chief Financial Officer Medical Properties Trust, Inc. MPT Operating Partnership, L.P. 1000 Urban Center Drive, Suite 501 Birmingham, AL 35242 Re: Medical Properties Trust, Inc. MPT Operating Partnership, L.P. Form 10-K for the Year Ended December 31, 2021 Filed March 1, 2022 File No. 001-32559 Dear R. Steven H
January 20, 2023	SC 13G	MPW / Medical Properties Trust, Inc. / BlackRock Inc. Passive Investment SC 13G 1 us58463j3041012023.txt us58463j3041012023.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: ) MEDICAL PROPERTIES TRUST INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 58463J304 - (CUSIP Number) December 31, 2022 - (Date of Event Which Requires Filing of this Statement) Check the appropri
November 9, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file n
November 2, 2022	CORRESP	November 2, 2022 November 2, 2022 VIA EDGAR United States Securities and Exchange Commission Division of Corporate Finance Office of Real Estate and Construction 100 F Street, NE Washington, D.
October 27, 2022	EX-99.2	MEDICAL PROPERTIES TRUST Q3 2022 SUPPLEMENTAL Exhibit 99.2 MEDICAL PROPERTIES TRUST Q3 2022 SUPPLEMENTAL COMPANY OVERVIEW Company Information 3 FINANCIAL INFORMATION Reconciliation of Net Income to Funds from Operations 6 Debt Summary 7 Adjusted Net Debt / Annualized EBITDAre 8 PORTFOLIO INFORMATION Adjusted Lease and Loan Maturity Schedule 9 Total Adjusted Gross Assets and Adjusted Revenues by Asset Type, Operator, State and Country 10 Rent
October 27, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 27, 2022 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of
October 27, 2022	EX-99.1	MEDICAL PROPERTIES TRUST, INC. REPORTS THIRD QUARTER RESULTS Per Share Net Income of $0.37 and Normalized FFO of $0.45 in Third Quarter Year-to-Date Capital Recycling Transactions Generate Approximately $1.8 Billion of Cash Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director of Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS THIRD QUARTER RESULTS Per Share Net Income of $0.37 and Normalized FFO of $0.45 in Third Quarter Year-to-Date Capital Recycling Transactions Generate Approximately $1.8 Billion of Cash
October 19, 2022	LETTER	LETTER United States securities and exchange commission logo October 19, 2022 R. Steven Hamner Chief Financial Officer Medical Properties Trust, Inc. MPT Operating Partnership, L.P. 1000 Urban Center Drive, Suite 501 Birmingham, AL 35242 Re: Medical Properties Trust, Inc. MPT Operating Partnership, L.P. Form 10-K for the Year Ended December 31, 2021 Filed March 1, 2022 File No. 001-32559 Dear R. Steven H
October 11, 2022	EX-99.1	MEDICAL PROPERTIES TRUST ANNOUNCES AUTHORIZATION OF STOCK REPURCHASE PROGRAM Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director ? Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST ANNOUNCES AUTHORIZATION OF STOCK REPURCHASE PROGRAM Birmingham, AL ? October 10, 2022 ? Medical Properties Trust, Inc. (the ?Company? or ?MPT?) (NYSE: MPW) today announced that its Board of Directors
October 11, 2022	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 11, 2022 MEDICAL PROPERTI UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 11, 2022 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of
September 28, 2022	CORRESP	September 28, 2022 September 28, 2022 VIA EDGAR United States Securities and Exchange Commission Division of Corporate Finance Office of Real Estate and Construction 100 F Street, NE Washington, D.
September 14, 2022	LETTER	LETTER United States securities and exchange commission logo September 14, 2022 R. Steven Hamner Chief Financial Officer Medical Properties Trust, Inc. MPT Operating Partnership, L.P. 1000 Urban Center Drive, Suite 501 Birmingham, AL 35242 Re: Medical Properties Trust, Inc. MPT Operating Partnership, L.P. Form 10-K for the Year Ended December 31, 2021 Filed March 1, 2022 File No. 001-32559 Dear R. Steven
August 9, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file number
August 8, 2022	S-8	As filed with the Securities and Exchange Commission on August 8, 2022 As filed with the Securities and Exchange Commission on August 8, 2022 File No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MEDICAL PROPERTIES TRUST, INC. (Exact name of registrant as specified in its charter) Maryland 20-0191742 (State or other jurisdiction of incorporation or organization) (I.R.S. E
August 8, 2022	EX-FILING FEES	Filing Fee Table Exhibit 107 Calculation of Filing Fee Table FORM S-8 (Form Type) MEDICAL PROPERTIES TRUST, INC.
August 3, 2022	EX-99.3	Pictured: Morton Hospital Investor Update AUGUST 2022 Exhibit 99.3 Pictured: Morton Hospital Investor Update AUGUST 2022 AT THE VERY HEART OF HEALTH CARE.® FORWARD-LOOKING STATEMENTS This presentation includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements can generally be identified by the use of for
August 3, 2022	EX-99.2	Medical properties trustQ2 2022 Supplemental Exhibit 99.2 Medical properties trustQ2 2022 Supplemental 3 COMPANY OVERVIEW Company Information 3 FINANCIAL INFORMATION Reconciliation of Net Income to Funds from Operations 6 6 Debt Summary 7 Pro Forma Net Debt / Annualized Adjusted EBITDAre 8 PORTFOLIO INFORMATION Pro Forma Lease and Loan Maturity Schedule 9 9 Total Pro Forma Gross Assets and Adjusted Revenue by Asset Type, Operator, State and
August 3, 2022	EX-99.1	MEDICAL PROPERTIES TRUST, INC. REPORTS SECOND QUARTER RESULTS Per Share Net Income of $0.32 and Normalized FFO of $0.46 in Second Quarter 7% Growth in Per Share NFFO Versus Prior-Year Quarter Expansion of Spain Footprint Includes New Relationship wit Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director of Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS SECOND QUARTER RESULTS Per Share Net Income of $0.32 and Normalized FFO of $0.46 in Second Quarter 7% Growth in Per Share NFFO Versus Prior-Year Quarter Expansion of Spain Footprint Inc
August 3, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 3, 2022 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of i
July 6, 2022	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 29, 2022 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Maryland Delaware 001-32559 333-177186 20-0191742 20-02
July 6, 2022	EX-1.1	Second Amended and Restated Revolving Credit and Term Loan Agreement, dated as of June 29, 2022, among Medical Properties Trust, Inc., MPT Operating Partnership, L.P., the several lenders from time to time party thereto, Bank of America, N.A., as syndication agent, and JPMorgan Chase Bank, N.A., as administrative agent EX-1.1 2 d379139dex11.htm EX-1.1 Exhibit 1.1 Execution Version SECOND AMENDED AND RESTATED REVOLVING CREDIT AND TERM LOAN AGREEMENT among MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P., as Borrower, The Several Lenders from Time to Time Parties Hereto, JPMORGAN CHASE BANK, N.A., as Administrative Agent BANK OF AMERICA, N.A., as Syndication Agent BARCLAYS BANK PLC, GOLDMAN SACHS BAN
May 27, 2022	8-K	Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 26, 2022 Medical Properties Trust, Inc. (Exact name of Registrant as Specified in Its Charter) Maryland 001-32559 20-0191742 (State or Other Jurisdiction of Incorporation) (Commis
May 10, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file numbe
April 28, 2022	EX-99.1	MEDICAL PROPERTIES TRUST, INC. REPORTS FIRST QUARTER RESULTS Per Share Net Income of $1.05 and Normalized FFO of $0.47 in First Quarter 12% Growth in Per Share NFFO Versus Prior-Year Quarter Acquisitions, Dispositions and Macquarie Partnership Consis Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director of Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS FIRST QUARTER RESULTS Per Share Net Income of $1.05 and Normalized FFO of $0.47 in First Quarter 12% Growth in Per Share NFFO Versus Prior-Year Quarter Acquisitions, Dispositions and Ma
April 28, 2022	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of
April 28, 2022	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confid
April 28, 2022	EX-99.2	2024 AUD Term Loan (A$1.2B) Fixed 2.450% 897,840 7.2% 3.325% Notes Due 2025 (€500M) (A) Fixed 3.325% (A) Fixed (C) 1.949% 2025 GBP Term Loan (£700M) 0.993% Notes Due 2026 (€500M) (A) Fixed 0.993% 5.250% Notes Due 2026 Fixed 5.250% Exhibit 99.2 Q1 2022 SUPPLEMENTAL FORWARD-LOOKING STATEMENTS COMPANY OVERVIEW Forward-looking statements involve known and 3 unknown risks, uncertainties and other factors that Company Information 3 may cause the actual results of the Company or future events to differ materially from those expressed in or underlying such forward-looking statements, including without limitation: Normalized FFO per
April 28, 2022	EX-99.3	® AT THE VERY HEART OF HEALTHCARE. Exhibit 99.3 HM Torrelodones ? Madrid, Spain INVESTOR UPDATE APRIL 2022 ? AT THE VERY HEART OF HEALTHCARE. FORWARD-LOOKING STATEMENTS This presentation includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements can generally be identified by the use o
April 28, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 28, 2022 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of i
March 18, 2022	EX-99.1	MEDICAL PROPERTIES TRUST COMPLETES HOSPITAL PARTNERSHIP WITH MACQUARIE ASSET MANAGEMENT $1.7 Billion Valuation and 47% Gain on Sale of Real Estate Point to Embedded Value in MPT’s Portfolio $1.3 Billion in Cash Proceeds to MPT to Reduce Debt Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director ? Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST COMPLETES HOSPITAL PARTNERSHIP WITH MACQUARIE ASSET MANAGEMENT $1.7 Billion Valuation and 47% Gain on Sale of Real Estate Point to Embedded Value in MPT?s Portfolio $1.3 Billion in Cash Proceeds to MP
March 18, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 16, 2022 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Commission File Numbe
March 1, 2022	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ?ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ?TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file n
March 1, 2022	EX-10.30	Amendment No. 2 to Amended and Restated Revolving Credit and Term Loan Agreement, dated as of November 22, 2021, among Medical Properties Trust, Inc., MPT Operating Partnership, L.P., the several lenders from time to time party thereto, and JPMorgan Chase Bank, N.A., as administrative agent Exhibit 10.30 AMENDMENT NO. 2 TO AMENDED AND RESTATED REVOLVING CREDIT AND TERM LOAN AGREEMENT This AMENDMENT NO. 2 TO AMENDED AND RESTATED REVOLVING CREDIT AND TERM LOAN AGREEMENT, dated as of November 22, 2021 (this ?Amendment No. 2?), is by and among MEDICAL PROPERTIES TRUST, INC., a Maryland corporation (?Holdings?), MPT OPERATING PARTNERSHIP, L.P., a Delaware limited partnership (the ?Borrowe
March 1, 2022	EX-21.1	Subsidiaries of Medical Properties Trust, Inc. EX-21.1 3 mpw-ex2117.htm EX-21.1 Exhibit 21.1 SUBSIDIARIES OF REGISTRANT Subsidiaries Jurisdiction of Organization Jurisdiction(s) in Which Qualified as a Foreign Corporation Medical Properties Trust, LLC Delaware Alabama, Massachusetts Mountain View-MPT Hospital, LLC Delaware Idaho MPT of Allen FCER, LLC Delaware Texas MPT of Altoona, LLC Delaware Wisconsin MPT of Alvarado, LLC Delaware Californi
February 23, 2022	EX-99.1	EMILY W. MURPHY APPOINTED TO THE BOARD OF DIRECTORS OF MEDICAL PROPERTIES TRUST Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director of Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] EMILY W. MURPHY APPOINTED TO THE BOARD OF DIRECTORS OF MEDICAL PROPERTIES TRUST Birmingham, AL ? February 23, 2022 ? Medical Properties Trust, Inc. (the ?Company? or ?MPT?) (NYSE: MPW) today announced the appointment of Emil
February 23, 2022	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 17, 2022 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction o
February 14, 2022	SC 13G/A	MPW / Medical Properties Trust, Inc. / COHEN & STEERS, INC. Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 (Exit Filing)* Medical Properties Trust Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 58463J304 (CUSIP Number) December 31, 2021 (Date of Event Which Req
February 11, 2022	SC 13G	MPW / Medical Properties Trust, Inc. / STATE STREET CORP Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 INITIAL FILING MEDICAL PROPERTIES TRUST INC (NAME OF ISSUER) REIT (TITLE OF CLASS OF SECURITIES) 58463J304 (CUSIP NUMBER) 12/31/2021 (DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT) CHECK THE APPROPRIATE BOX TO DESIGNATE THE RULE PURSUANT TO WHICH THIS SCHEDULE IS F
February 10, 2022	SC 13G/A	MPW / Medical Properties Trust, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 16)* Name of issuer: Medical Properties Trust Inc. Title of Class of Securities: REIT CUSIP Number: 58463J304 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed
February 4, 2022	SC 13G/A	MPW / Medical Properties Trust, Inc. / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Medical Properties Trust, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 58463J304 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to wh
February 3, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 3, 2022 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of
February 3, 2022	EX-99.2	MPT Medical Properties Trust SUPPLEMENTAL Q4 Exhibit 99.2 MPT Medical Properties Trust SUPPLEMENTAL Q4 3 (COMPANY)OVERVIEW Company Information 3 FINANCIAL INFORMATION Reconciliation of Net Income to Funds from Operations 6 6 Debt Summary 7 Debt Maturity Schedule 8 Pro Forma Net Debt /Annualized Adjusted EBITDA 9 PORTFOLIO INFORMATION Pro Forma Lease and Loan Maturity Schedule 10 10 (Total)Pro Forma Gross Assets and Adjusted Revenue by Asset
February 3, 2022	EX-99.1	MEDICAL PROPERTIES TRUST, INC. REPORTS FOURTH QUARTER AND FULL-YEAR RESULTS Per Share Net Income of $0.34 and Normalized FFO of $0.47 in Fourth Quarter Robust Double-Digit Growth in Full-Year Net Income, NFFO and AFFO per Share $3.9 Billion of Invest Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director of Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS FOURTH QUARTER AND FULL-YEAR RESULTS Per Share Net Income of $0.34 and Normalized FFO of $0.47 in Fourth Quarter Robust Double-Digit Growth in Full-Year Net Income, NFFO and AFFO per Sh
January 28, 2022	SC 13G/A	MPW / Medical Properties Trust, Inc. / BlackRock Inc. Passive Investment us58463j3041012822.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 14) MEDICAL PROPERTIES TRUST INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 58463J304 - (CUSIP Number) December 31, 2021 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule
January 3, 2022	EX-25.1	Statement of Eligibility on Form T-1 Exhibit 25.1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 ? Check if an Application to Determine Eligibility of a Trustee Pursuant to Section 305(b)(2) WILMINGTON TRUST, NATIONAL ASSOCIATION (Exact name of trustee as specified in its charter) 16-1486454 (I.R.S. employer identification no.) 1100 North Market Street Wilmington, DE 19890-0001 (Address of principal
January 3, 2022	S-3ASR	As filed with the Securities and Exchange Commission on December 30, 2021 Table of Contents As filed with the Securities and Exchange Commission on December 30, 2021 Registration No.
November 9, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file n
November 9, 2021	EX-10.2	Amendment to Amended and Restated Revolving Credit and Term Loan Agreement, dated as of September 29, 2021, among Medical Properties Trust, Inc., MPT Operating Partnership, L.P., the several lenders from time to time party thereto, Bank of America, N.A., as syndication agent, and JPMorgan Chase Bank, N.A., as administrative agent EX-10.2 3 mpw-ex102106.htm EX-10.2 Exhibit 10.2 AMENDMENT NO. 1 TO AMENDED AND RESTATED REVOLVING CREDIT AND TERM LOAN AGREEMENT This AMENDMENT NO. 1 TO AMENDED AND RESTATED REVOLVING CREDIT AND TERM LOAN AGREEMENT, dated as of September 29, 2021 (this “Amendment No. 1”), is by and among MEDICAL PROPERTIES TRUST, INC., a Maryland corporation (“Holdings”), MPT OPERATING PARTNERSHIP, L.P., a Delawar
November 9, 2021	EX-10.1	Amended and Restated Master Lease Agreement between certain subsidiaries of MPT Operating Partnership, L.P. as Lessor and certain subsidiaries of Steward Health Care System LLC, Lessee EXHIBIT 10.1 AMENDED AND RESTATED MASTER LEASE AGREEMENT BY AND AMONG THE ENTITIES LISTED ON SCHEDULE 1-A ATTACHED HERETO, (collectively, jointly and severally, ?Lessor?) AND THE ENTITIES LISTED ON SCHEDULE 1-B ATTACHED HERETO, (collectively, jointly and severally, as ?Lessee?) August 27, 2021 4834-1440-2281v12 Table of Contents Page ARTICLE I. DEFINITIONS 3 1.1. Certain Defined Terms 3 1.2. Inter
October 28, 2021	EX-99.2	Medical Properties Trust SUPPLEMENTAL Q3 Exhibit 99.2 Medical Properties Trust SUPPLEMENTAL Q3 3 COMPANY OVERVIEW Company Information 3 FINANCIAL INFORMATION Reconciliation of Net Income to Funds from Operations 6 6 Debt Summary 7 Debt Maturity Schedule 8 Pro Forma Net Debt /Annualized Adjusted EBITDA 9 PORTFOLIO INFORMATION Pro Forma Lease and Loan Maturity Schedule 10 10 Total Pro Forma Gross Assets and Adjusted Revenue by Asset Type,
October 28, 2021	EX-99.1	MEDICAL PROPERTIES TRUST, INC. REPORTS THIRD QUARTER RESULTS Per Share Net Income of $0.29 and Normalized FFO of $0.44 in Third Quarter Double-Digit Per Share NFFO and AFFO Growth Year-to-Date in 2021 Versus Prior-Year Period Announced Transactions E EX-99.1 2 d403434dex991.htm EX-99.1 Exhibit 99.1 Contact: Drew Babin, CFA Senior Managing Director of Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS THIRD QUARTER RESULTS Per Share Net Income of $0.29 and Normalized FFO of $0.44 in Third Quarter Double-Digit Per Share NFFO and AFFO Growth Year-to-Date
October 28, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 28, 2021 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of
October 13, 2021	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 6, 2021 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Maryland Delaware 001-32559 333-177186 20-0191742 20-
October 13, 2021	EX-4.2	Nineteenth Supplemental Indenture, dated as of October 6, 2021, by and among MPT Operating Partnership, L.P. and MPT Finance Corporation, as issuers, Medical Properties Trust, Inc., as parent and guarantor, Wilmington Trust, National Association, as trustee, and Elavon Financial Services DAC, as initial paying agent, registrar and transfer agent Exhibit 4.2 Execution Version MPT OPERATING PARTNERSHIP, L.P. and MPT FINANCE CORPORATION, as Issuers, MEDICAL PROPERTIES TRUST, INC., as Parent and a Guarantor WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee and ELAVON FINANCIAL SERVICES DAC, as Paying Agent, Registrar and Transfer Agent 0.993% Senior Notes due 2026 NINETEENTH SUPPLEMENTAL INDENTURE Dated as of October 6, 2021 CROSS-REFERENCE
September 28, 2021	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 22, 2021 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Maryland Delaware 001-32559 333-177186 20-0191742
September 28, 2021	EX-1.1	Underwriting Agreement, dated September 22, 2021, among the Issuers, the Company and Barclays Bank PLC, Goldman Sachs & Co. LLC, J.P. Morgan Securities plc and Merrill Lynch International, as representatives of the several underwriters named therein Exhibit 1.1 ?500,000,000 MPT OPERATING PARTNERSHIP, L.P. MPT FINANCE CORPORATION 0.993% Senior Notes due 2026 UNDERWRITING AGREEMENT September 22, 2021 Barclays Bank PLC 5 The North Colonnade Canary Wharf London E14 4BB United Kingdom Goldman Sachs & Co. LLC 200 West Street New York, New York 10282 J.P. Morgan Securities plc 25 Bank Street Canary Wharf London E14 5JP United Kingdom Merrill Lynch I
September 24, 2021	424B2	CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to be Registered Amount to be Registered(1) Maximum Offering Price Per Unit Maximum Aggregate Offering Price(1) Amount of Registration Fee 0.993% Senior Notes due 2026 $584,350,000 100 Table of Contents Filed Pursuant to Rule 424(b)(2) Registration Nos. 333-229103, 333-229103-01 and 333-229103-02 CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to be Registered Amount to be Registered(1) Maximum Offering Price Per Unit Maximum Aggregate Offering Price(1) Amount of Registration Fee 0.993% Senior Notes due 2026 $584,350,000 100.000% $584,350,000 $63,752.59(2) Guar
September 22, 2021	424B5	Subject to Completion, dated September 22, 2021 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration Nos. 333-229103, 333-229103-01 and 333-229103-02 The information in this preliminary prospectus supplement is not complete and may be changed. A registration statement relating to the securities has become effective under the Securities Act of 1933, as amended. This preliminary prospectus supplement and the accompanying prospectus do
September 22, 2021	FWP	2 Issuer Free Writing Prospectus filed pursuant to Rule 433 supplementing the Preliminary Prospectus Supplement dated September 22, 2021 Registration Nos.
September 1, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 1, 2021 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Commission File Nu
September 1, 2021	EX-99.1	MEDICAL PROPERTIES TRUST AND MACQUARIE INFRASTRUCTURE PARTNERS V ENTER PARTNERSHIP FOR EIGHT MASSACHUSETTS HOSPITALS VALUED AT $1.78 BILLION Expected Cash Proceeds to MPT of $1.3 Billion to Repay Debt and Fund Previously Announced Investments in Inpa Exhibit 99.1 Contact: Drew Babin, CFA Senior Managing Director ? Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST AND MACQUARIE INFRASTRUCTURE PARTNERS V ENTER PARTNERSHIP FOR EIGHT MASSACHUSETTS HOSPITALS VALUED AT $1.78 BILLION Expected Cash Proceeds to MPT of $1.3 Billion to Repay Debt and Fund Previously Announced
August 9, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file number
July 29, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 29, 2021 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of in
July 29, 2021	EX-99.1	MEDICAL PROPERTIES TRUST, INC. REPORTS SECOND QUARTER RESULTS Per Share Net Income of $0.19 and Normalized FFO of $0.43 in Second Quarter Per Share NFFO and AFFO Growth Exceeding 13% Compared to Prior-Year Quarter Year-to-Date Investments of More tha Exhibit 99.1 Contact: Drew Babin, CFA Senior Managing Director ? Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS SECOND QUARTER RESULTS Per Share Net Income of $0.19 and Normalized FFO of $0.43 in Second Quarter Per Share NFFO and AFFO Growth Exceeding 13% Compared to Prior-Year Quarter Year-to-Date Inv
July 29, 2021	EX-99.2	Medical Properties Trust Q2 SUPPLEMENTAL 2021 Exhibit 99.2 Medical Properties Trust Q2 SUPPLEMENTAL 2021 3 COMPANY OVERVIEW Company Information 3 FINANCIAL INFORMATION Reconciliation of Net Income to Funds from Operations 6 6 Debt Summary 7 Debt Maturity Schedule 8 Pro Forma Net Debt /Annualized Adjusted EBITDA 9 PORTFOLIO INFORMATION Lease and Loan Maturity Schedule 10 10 Total Pro Forma Gross Assets and Adjusted Revenue by Asset Type, Opera
June 9, 2021	EX-99.1	Consolidated Financial Statements of Steward Health Care System LLC as of December 31, 2020 and 2019 Exhibit 99.1 Steward Health Care System LLC Consolidated Financial Statements Years Ended December 31, 2020 and 2019 (With Independent Auditors? Report Thereon) Steward Health Care System LLC Consolidated Financial Statements Years ended December 31, 2020 and 2019 Contents Page Independent Auditors? Report 1 Consolidated Balance Sheets 5 Consolidated Statements of Operations 6 Consolidated Stateme
June 9, 2021	EX-99.1	® AT THE VERY HEART OF HEALTHCARE.® AT THE VERY HEART OF HEALTHCARE. Exhibit 99.1 Reading Hospital near London, UK REITweek: 2021 Investor Conference JUNE 2021Exhibit 99.1 Reading Hospital near London, UK REITweek: 2021 Investor Conference JUNE 2021 ? AT THE VERY HEART OF HEALTHCARE.? AT THE VERY HEART OF HEALTHCARE. FORWARD-LOOKING STATEMENTS This presentation includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as a
June 9, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 9, 2021 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Maryland 001-32559 20-0191742 (State or other jurisdiction of incorporation or organizat
June 9, 2021	10-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ?ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ?TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-325
May 28, 2021	8-K	Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 26, 2021 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Maryland 001-32559 20-0191742 (State or other jurisdiction of incorporation or organizat
May 10, 2021	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file numbe
May 10, 2021	EX-10.1	Amended and Restated Revolving Credit and Term Loan Agreement, dated as of January 15, 2021, among Medical Properties Trust, Inc., MPT Operating Partnership, L.P., the several lenders from time to time party thereto, Bank of America, N.A., as syndication agent, and JPMorgan Chase Bank, N.A., as administrative agent Execution Version Exhibit 10.1 AMENDED AND RESTATED REVOLVING CREDIT AND TERM LOAN AGREEMENT among MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P., as Borrower, The Several Lenders from Time to Time Parties Hereto, JPMORGAN CHASE BANK, N.A., as Administrative Agent BANK OF AMERICA, N.A., as Syndication Agent BARCLAYS BANK PLC, GOLDMAN SACHS BANK USA, KEYBANK NATIONAL ASSOCIATION, CI
April 29, 2021	EX-99.2	Q SUPPLEMENTAL 1 2021 Exhibit 99.2 Q SUPPLEMENTAL 1 2021 3 COMPANY OVERVIEW Company Information 3 FINANCIAL INFORMATION Reconciliation of Net Income to Funds from Operations 6 6 Debt Summary 7 Debt Maturity Schedule 8 Pro Forma Net Debt /Annualized Adjusted EBITDA 9 PORTFOLIO INFORMATION Lease and Loan Maturity Schedule 10 10 Total Pro Forma Gross Assets and Adjusted Revenue by Asset Type, Operator, State and Country 1
April 29, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 29, 2021 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of i
April 29, 2021	EX-99.1	MEDICAL PROPERTIES TRUST, INC. REPORTS FIRST QUARTER RESULTS Per Share Net Income of $0.28 and Normalized FFO of $0.42 in First Quarter Per Share NFFO Growth Exceeding 13% Compared to Prior-Year Quarter Year-to-Date Investments of Approximately $1.6 Exhibit 99.1 Contact: Drew Babin, CFA Senior Managing Director ? Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS FIRST QUARTER RESULTS Per Share Net Income of $0.28 and Normalized FFO of $0.42 in First Quarter Per Share NFFO Growth Exceeding 13% Compared to Prior-Year Quarter Year-to-Date Investments of
April 26, 2021	DEFA14A	- DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (RULE 14A-101) PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definit
April 26, 2021	DEF 14A	Schedule 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (RULE 14A-101) PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definit
March 29, 2021	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 24, 2021 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Maryland Delaware 001-32559 333-177186 20-0191742 20-0
March 29, 2021	EX-4.2	Seventeenth Supplemental Indenture, dated as of March 24, 2021, by and among MPT Operating Partnership, L.P. and MPT Finance Corporation, as issuers, Medical Properties Trust, Inc., as parent and guarantor, Wilmington Trust, National Association, as trustee, and Elavon Financial Services DAC, as initial paying agent, registrar and transfer agent Exhibit 4.2 Execution Version MPT OPERATING PARTNERSHIP, L.P. and MPT FINANCE CORPORATION, as Issuers, MEDICAL PROPERTIES TRUST, INC., as Parent and a Guarantor WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee and ELAVON FINANCIAL SERVICES DAC, as Paying Agent, Registrar and Transfer agent 2.500% Senior Notes due 2026 SEVENTEENTH SUPPLEMENTAL INDENTURE Dated as of March 24, 2021 CROSS-REFERENCE
March 29, 2021	EX-4.4	Eighteenth Supplemental Indenture, dated as of March 24, 2021, by and among MPT Operating Partnership, L.P. and MPT Finance Corporation, as issuers, Medical Properties Trust, Inc., as parent and guarantor, Wilmington Trust, National Association, as trustee, and Elavon Financial Services DAC, as initial paying agent, registrar and transfer agent Exhibit 4.4 Execution Version MPT OPERATING PARTNERSHIP, L.P. and MPT FINANCE CORPORATION, as Issuers, MEDICAL PROPERTIES TRUST, INC., as Parent and a Guarantor WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee and ELAVON FINANCIAL SERVICES DAC, as Paying Agent, Registrar and Transfer agent 3.375% Senior Notes due 2030 EIGHTEENTH SUPPLEMENTAL INDENTURE Dated as of March 24, 2021 CROSS-REFERENCE T
March 22, 2021	EX-1.1	Underwriting Agreement, dated March 17, 2021, among the Issuers, the Company and Goldman Sachs & Co. LLC, Barclays Bank PLC, J.P. Morgan Securities plc and Merrill Lynch International, as representatives of the several underwriters named therein Exhibit 1.1 UNDERWRITING AGREEMENT MPT OPERATING PARTNERSHIP, L.P. MPT FINANCE CORPORATION ?500 million 2.500% Senior Notes due 2026 ?350 million 3.375% Senior Notes due 2030 March 17, 2021 Goldman Sachs & Co. LLC 200 West Street New York, New York 10282 Barclays Bank PLC 5 The North Colonnade Canary Wharf London E14 4BB United Kingdom J.P. Morgan Securities plc 25 Bank Street Canary Wharf London
March 22, 2021	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 17, 2021 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Maryland Delaware 001-32559 333-177186 20-0191742 20-0
March 19, 2021	424B2	CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to be Registered Amount to be Registered(1) Maximum Offering Price Per Unit Maximum Aggregate Offering Price(1) Amount of Registration Fee 2.500% Senior Notes due 2026 $698,300,000 99. Table of Contents Filed Pursuant to Rule 424(b)(2) Registration Nos. 333-229103, 333-229103-01 and 333-229103-02 CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to be Registered Amount to be Registered(1) Maximum Offering Price Per Unit Maximum Aggregate Offering Price(1) Amount of Registration Fee 2.500% Senior Notes due 2026 $698,300,000 99.937% $697,860,071.00 $76,136.54(2) 3.
March 17, 2021	424B5	Subject to Completion, dated March 17, 2021 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration Nos. 333-229103, 333-229103-01 and 333-229103-02 The information in this preliminary prospectus supplement is not complete and may be changed. A registration statement relating to the securities has become effective under the Securities Act of 1933, as amended. This preliminary prospectus supplement and the accompanying prospectus do
March 17, 2021	FWP	2.500% Senior Notes due 2026 Aggregate Principal Amount: £500,000,000 Title of Securities: 2.500% Senior Notes due 2026 (the “2026 Notes”) Final Maturity Date: March 24, 2026 Public Offering Price: 99.937% Coupon: 2.500% Yield to Maturity: 2.514% Spr Issuer Free Writing Prospectus filed pursuant to Rule 433 supplementing the Preliminary Prospectus Supplement dated March 17, 2021 Registration Nos.
March 1, 2021	10-K	Annual Report - 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ?ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ?TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file n
March 1, 2021	EX-21.1	Subsidiaries of Medical Properties Trust, Inc. Exhibit 21.1 SUBSIDIARIES OF REGISTRANT Subsidiaries Jurisdiction of Organization Jurisdiction(s) in Which Qualified as a Foreign Corporation Medical Properties Trust, LLC Delaware Alabama, Massachusetts Mountain View-MPT Hospital, LLC Delaware Idaho MPT of Allen FCER, LLC Delaware Texas MPT of Altoona, LLC Delaware Wisconsin MPT of Alvarado, LLC Delaware California MPT of Alvarado, L.P. Delaware
February 16, 2021	SC 13G/A	SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1) Medical Properties Trust, Inc. - (Name of Issuer) Common Stock - (Title of Class of Securities) 58463J304 - (CUSIP Number) Date of Event which Requires Filing of this Statement December 31, 2020 - Check the appropriate box to designate the rule pursuant t
February 10, 2021	SC 13G/A	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 15)* SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 15)* Name of issuer: Medical Properties Trust Inc. Title of Class of Securities: REIT CUSIP Number: 58463J304 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is filed
February 4, 2021	EX-99.2	4 Q Supplemental 2020 EX-99.2 Exhibit 99.2 4 Q Supplemental 2020 3 COMPANY OVERVIEW Company Information 3 FINANCIAL INFORMATION Reconciliation of Net Income to Funds from Operations 6 6 Debt Summary 7 Debt Maturity Schedule 8 Pro Forma Net Debt /Annualized Adjusted EBITDA 9 PORTFOLIO INFORMATION Lease and Loan Maturity Schedule 10 10 Total Pro Forma Gross Assets and Adjusted Revenue by Asset Type, Operator, State and C
February 4, 2021	SC 13G	SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Medical Properties Trust, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 58463J304 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whic

GB:0JZZ	5,01 $
DE:M3P	4,32 €

MPT / Medical Properties Trust, Inc. - SEC-arkivering, Årsberetning, Fuldmagtserklæring

Grundlæggende statistik

SEC Filings

SEC Filings (Chronological Order)

How Much do you Like Fintel?

Write a Review and get 25% Off Your Next Purchase

How can we Improve?

Other Listings